Advertisement
Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Cancer Risk Linked to DNA 'Wormholes'

February 20, 2015 8:50 am | by Institute of Cancer Research | News | Comments

Single-letter genetic variations within parts of the genome once dismissed as ‘junk DNA’ can increase cancer risk. Read more...                      

TOPICS:

UN Ebola Chief Hails Successes, Warns of Fatigue

February 20, 2015 8:47 am | by Jonathan Paye-Layleh, Associated Press | News | Comments

The head of the United Nations Mission for Ebola Emergency Response hailed Liberia's success in the fight against the deadly Ebola virus. Read more...                  

TOPICS:

The Journey to an HIV Vaccine Endures

February 19, 2015 12:46 pm | by Stephanie Guzowski, Editor | Articles | Comments

Despite more than 30 years of efforts, scientists have not yet come up with a reliably effective HIV vaccine — in part, because of the inherently complicated nature of the virus. Here are where their research efforts stand today.

TOPICS:
Advertisement

VirMedica Makes Capital Investment in D2 Pharma Consulting

February 19, 2015 10:12 am | by D2 | News | Comments

VirMedica, Inc., a leading provider of technology solutions designed to optimize the commercialization of specialty pharmaceutical products, announced that it has made a significant capital investment in D2 Pharma Consulting, LLC ("D2"). Read more...

TOPICS:

Cholesterol Count Results: Most Americans Don't Know LDL-C Levels

February 19, 2015 10:07 am | by Sanofi | News | Comments

Despite the fact that high LDL-C (bad cholesterol) is a critical heart health factor for adults,1 71 percent of Americans surveyed (n=2,033) are not sure of or do not recall their LDL-C (bad cholesterol) levels, according to the initial results from the Cholesterol Counts Poll released during American Heart Month. Read more...

TOPICS:

Development of Personalized Cellular Therapy for Brain Cancer

February 19, 2015 9:55 am | by UPenn | News | Comments

Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsylvania and the Novartis Institutes for BioMedical Research. Read more...

TOPICS:

New Nanogel for Drug Delivery

February 19, 2015 9:39 am | by MIT | News | Comments

Scientists are interested in using gels to deliver drugs because they can be molded into specific shapes and designed to release their payload over a specified time period. However, current versions aren’t always practical because must be implanted surgically. Read more...

TOPICS:

7 Infected, 2 Dead After 'Superbug' Outbreak at Hospital

February 19, 2015 9:30 am | by Robert Jablon, Associated Press | News | Comments

Contaminated medical instruments are to blame for infecting seven patients - including two who died - with an antibiotic-resistant and potentially deadly "superbug" at Ronald Reagan UCLA Medical Center, hospital officials said. A total of 179 patients may be infected. Read more....

TOPICS:
Advertisement

Health Groups Say AIDS No. 1 Killer of Adolescents in Africa

February 18, 2015 3:03 pm | by Tom Odula, Associated Press | News | Comments

Global health organizations said Tuesday that AIDS is now the leading cause of death for adolescents in Africa, and the second leading cause of death among adolescents globally. Read more...            

TOPICS:

Study Highlights Drug Targets for Allergies, Asthma

February 18, 2015 2:56 pm | by Sam Wong, Imperial College London | News | Comments

The new findings could lead to new treatments for allergic diseases, and will help to predict who will best respond to currently available treatments. Read more...                

TOPICS:

The Ebola Era

February 18, 2015 2:45 pm | by Harvard Medical School | News | Comments

This event will convene international experts in virology, infectious disease, vaccines and therapeutics. They will discuss strategies both to combat the current Ebola outbreak. Read more...            

TOPICS:

More Measles Cases Tied to Disneyland, Illinois Day Care

February 18, 2015 2:39 pm | by Mike Stobbe, AP Medical Writer | News | Comments

The number of U.S. measles cases this year has risen to 141, with most of the new illnesses tied to outbreaks at Disneyland in California and an Illinois day care center. Read more...             

TOPICS:

Scientists Announce Anti-HIV Agent So Powerful It Can Work in a Vaccine

February 18, 2015 2:34 pm | by Scripps Research Institute | News | Comments

Scientists have announced the creation of a novel drug candidate that is so potent and universally effective, it might work as part of an unconventional vaccine. Read more...              

TOPICS:

Is Strenuous Running Really as Bad for Health as Lounging?

February 18, 2015 11:10 am | by Cynthia Fox, Science Editor | News | Comments

Running hard may be as bad for your longevity as being a couch potato, says a recent study—one that should be taken with a grain of salt (hold the butter), say some critics. The study, in a recent Journal of the American College of Cardiology, examined 5,048 healthy people enrolled in the Copenhagen City Heart Study. For 12 years, 1,098 healthy joggers and 413 healthy, but sedentary non-joggers were followed.

TOPICS:

FDA Expands Indications for Revlimid

February 18, 2015 10:40 am | by Associated Press | News | Comments

Celgene Corporation announced that the U.S. Food and Drug Administration (FDA) has expanded the existing indication for Revlimid (lenalidomide) in combination with dexamethasone to include patients newly diagnosed with multiple myeloma (NDMM). Read more..

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading